Cargando…

491. Risk Factors for Severe Pediatric COVID-19: A Systematic Review

BACKGROUND: Optimal management of COVID-19 in children requires risk stratification based on comorbidities and demographic factors that can predispose to severe disease. The Pediatric Infectious Diseases Society (PIDS) Pediatric COVID-19 Therapies Task Force, comprised of pediatric infectious diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Carlos R, Willis, Zachary I, Maron, Gabriela, Sue, Paul K, Anosike, Brenda I, Bio, Laura, Singh, Prachi, James, Scott H, Miller, Christine M, Nakamura, Mari M, Wolf, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678737/ http://dx.doi.org/10.1093/ofid/ofad500.560

Ejemplares similares

SAT-491 Severe Hypercalcemia Secondary to Primary Skeletal Sarcoidosis
por: Dbeis, Ammer, et al.
Publicado: (2019)

SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)

2948. Pediatric Clinical Outcomes of MRSA PCR Utilization for Anti-MRSA De-escalation
por: Demirhan, Salih, et al.
Publicado: (2023)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

491 Outcomes of an Integrated Research Ethics Consultation Service
por: Smith, Elise, et al.
Publicado: (2023)

THU491 GRHL2 Overexpression In Breast Cancer Progression
por: Zheng, Christy, et al.
Publicado: (2023)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

491 Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-training
por: Pun, Teresa, et al.
Publicado: (2012)

FRI491 The Impact Of Insulin Resistance On Thyroid Function In Pregnancy
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2023)

473. Clinical Outcomes of a Pediatric COVID Monoclonal Antibody Program based at an Urban Academic Center
por: Lee, Philip J, et al.
Publicado: (2021)

MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells
por: Yu, Ting, et al.
Publicado: (2016)

491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children
por: Dolan, Susan, et al.
Publicado: (2021)

491. Characterizing the Association of Pre-Existing Cytomegalovirus (CMV)-specific Humoral Immunity with CMV Reactivation Risk after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2022)

Piano concerto no. 24, K491 ; Piano concerto no. 25, K503
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1990)

491 Comparative Effectiveness of Single vs Combination Antibiotic Prophylaxis for TRUS-biopsy
por: Marino, Kaylee, et al.
Publicado: (2014)

Comments on Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Foster, Keith, et al.
Publicado: (2020)

SUN-491 A Diagnosis of Thyroid Cancer Reveals a Triple Threat
por: Dengler, Samuel Lee, et al.
Publicado: (2020)

Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1
por: Darrigo Junior, Luiz Guilherme, et al.
Publicado: (2022)

523. Efficacy and Safety of Nirmatrelvir/Ritonavir for COVID-19 in Adolescents
por: Lee, Kiriam Escobar, et al.
Publicado: (2023)

Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells
por: Ding, Hui, et al.
Publicado: (2022)

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
por: Li, Xia, et al.
Publicado: (2014)

Heterologous transplantation of a tissue culture line of a human melanoma (TC491).
por: Manuelidis, E. E.
Publicado: (1971)

miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro
por: Qi, Zengxin, et al.
Publicado: (2016)

SAT-491 Transient Thyrotoxicosis with Immune Checkpoint Inhibitors Therapy: The Importance of Endocrine Evaluation
por: Martins, Diana Cruz, et al.
Publicado: (2020)

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020)

eP491: COVID-19 and clinical genomics: A Detroit community hospital’s telehealth experience
por: Jay, Allison, et al.
Publicado: (2022)

MON-491 TRK-Fusion Thyroid Cancer: A Clinical Overview in a Large Population at a Single Cancer Center
por: Fazeli, Sasan, et al.
Publicado: (2020)

Regulation of the localisation and function of the oncogene LYRIC/AEG‐1 by ubiquitination at K486 and K491
por: Luxton, Hayley J., et al.
Publicado: (2014)

PM491. The Neurodevelopmental Profile of Group 1 Metabotropic Glutamate Receptors: Implications for Novel Therapeutics
por: Lum, Jeremy S., et al.
Publicado: (2016)

miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2
por: Chen, Ting, et al.
Publicado: (2018)

491. Aerosol-Generating Medical Procedures: Transmission of SARS-CoV-2 and Emerging Viruses
por: Judson, Seth D, et al.
Publicado: (2020)

microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9
por: He, Zhonghan, et al.
Publicado: (2020)

Ginsenoside Rh2 Suppresses Metastasis and Growth of Colon Cancer via miR-491
por: Wei, Wene, et al.
Publicado: (2021)

Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury
por: Tang, Wei, et al.
Publicado: (2021)

SAT491 Development of Thyroidal Nodule in Congenital Hypothyroid Girl With Thyroid Peroxidase Gene Mutation
por: Lee, Jisu, et al.
Publicado: (2023)

491. Clinical Manifestations and Outcomes of Clostridium difficile Infection in Long-Term Care Patients: An 8-Year Retrospective Cohort Study
por: Chandramohan, Suganya, et al.
Publicado: (2018)

Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors
por: de Souza, Gustavo A, et al.
Publicado: (2006)

Activation and Suppression of a Cryptic Promoter in the Intron of the Human Melanoma‐associated ME491 Antigen Gene
por: Takahashi, Nobuo, et al.
Publicado: (1991)

Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Bellows, Steven, et al.
Publicado: (2020)

miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4
por: Wu, Fuyong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17qki0eqsvbsuj82lt9ekk32ro